 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              The Board of Directors of Venus Remedies Ltd in its meeting held today have allotted 9,00,000 Equity Shares of face value of Rs. 10 each at a price of Rs. 88.77 (Rupees Eighty Eight and seventy seven paise only) to promoters of the Company on conversion of fully convertible warrants on preferential basis.
Shares of VENUS REMEDIES LTD. was last trading in BSE at Rs.100.5 as compared to the previous close of Rs. 102.95. The total number of shares traded during the day was 16943 in over 263 trades.
The stock hit an intraday high of Rs. 103.25 and intraday low of 100.2. The net turnover during the day was Rs. 1715955.